AbbVie (ABBV) Insider Trading & Ownership $175.58 +4.06 (+2.37%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends AbbVie (NYSE:ABBV) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.25%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)8Amount OfInsider Selling(Last 12 Months)$130.44 M Get ABBV Insider Trade Alerts Want to know when executives and insiders are buying or selling AbbVie stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ABBV Insider Buying and Selling by Quarter Ad Behind the MarketsWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol AbbVie Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/16/2024Kevin K BuckbeeSVPSell1,800$172.24$310,032.00 11/20/2024Marjorie Taylor GreeneU.S. Congress Member (R-GA)Buy$167.74$1,001 - $15,0009/4/2024John JamesU.S. Congress Member (R-MI)Sell$197.00$1,001 - $15,0008/5/2024Richard A GonzalezChairmanSell66,500$186.52$12,403,580.00 7/17/2024Richard A GonzalezChairmanSell282,845$175.00$49,497,875.00 7/2/2024Kathy E. ManningU.S. Congress Member (D-NC)Buy$165.97$1,001 - $15,0004/10/2024Michael C. BurgessU.S. Congress Member (R-TX)Sell$168.99$1,001 - $15,0004/3/2024Tommy TubervilleU.S. Congress Member (R-AL)Buy$177.34$1,001 - $15,0003/20/2024Nicholas DonoghoeEVPSell21,082$176.30$3,716,756.60 3/18/2024Jeffrey Ryan StewartEVPSell58,949$178.79$10,539,491.71 2/29/2024Kevin K BuckbeeSVPSell5,144$176.65$908,687.60 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 2/29/2024Perry C SiatisEVPSell9,891$177.39$1,754,564.49 2/29/2024Robert A MichaelCOOSell68,879$176.45$12,153,699.55 2/28/2024Richard A GonzalezCEOSell138,616$177.27$24,572,458.32 2/23/2024Perry C SiatisEVPSell13,753$177.51$2,441,295.03 2/23/2024Scott T ReentsCFOSell14,140$177.44$2,509,001.60 2/21/2024Azita Saleki-GerhardtEVPSell52,870$173.71$9,184,047.70 1/23/2024Kathy E. ManningU.S. Congress Member (D-NC)Buy$167.51$1,001 - $15,0001/19/2024Tommy TubervilleU.S. Congress Member (R-AL)Sell$164.77$1,001 - $15,00012/26/2023Nicholas DonoghoeEVPSell2,912$154.72$450,544.64 (Data available from 1/1/2013 forward) ABBV Insider Trading Activity - Frequently Asked Questions Who is on AbbVie's Insider Roster? The list of insiders at AbbVie includes Azita Saleki-Gerhardt, Brian L Durkin, Carrie C Strom, Elaine K Sorg, Henry O Gosebruch, Jeffrey Ryan Stewart, Kevin K Buckbee, Michael Severino, Nicholas Donoghoe, Perry C Siatis, Richard A Gonzalez, Robert A Michael, Roxanne S Austin, Scott T Reents, and Timothy J Richmond. Learn more on insiders at ABBV. What percentage of AbbVie stock is owned by insiders? 0.25% of AbbVie stock is owned by insiders. Learn more on ABBV's insider holdings. Which AbbVie insiders have been selling company stock? The following insiders have sold ABBV shares in the last 24 months: Azita Saleki-Gerhardt ($12,922,297.70), Carrie C Strom ($4,310,832.64), Elaine K Sorg ($6,950,048.39), Jeffrey Ryan Stewart ($18,629,366.71), Kevin K Buckbee ($1,218,719.60), Nicholas Donoghoe ($4,167,301.24), Perry C Siatis ($6,616,685.32), Richard A Gonzalez ($89,233,188.32), Robert A Michael ($12,153,699.55), Roxanne S Austin ($1,505,000.00), and Scott T Reents ($4,949,402.96). How much insider selling is happening at AbbVie? Insiders have sold a total of 947,778 AbbVie shares in the last 24 months for a total of $162,656,542.43 sold. Which members of congress are trading AbbVie? Marjorie Taylor Greene (R-GA), Kathy E. Manning (D-NC), and Tommy Tuberville (R-AL) have bought shares of AbbVie in the last year totaling $32,000. John James (R-MI), Michael C. Burgess (R-TX), and Tommy Tuberville (R-AL) have sold shares totaling $24,000. AbbVie Key ExecutivesMr. Richard A. Gonzalez (Age 70)Chairman & CEO Compensation: $7.19M2 recent tradesMr. Robert A. Michael (Age 54)President & COO Compensation: $4.62MMr. Scott T. Reents (Age 56)Executive VP & CFO Compensation: $3.13MDr. Azita Saleki-Gerhardt Ph.D. (Age 61)Executive VP & COO Compensation: $3.51MMr. Jeffrey Ryan Stewart (Age 55)Executive VP & Chief Commercial Officer Compensation: $4.32MDr. Thomas J. Hudson M.D. (Age 62)Senior VP & Chief Scientific Officer of Global Research Ms. Elizabeth SheaSenior Vice President of Investor RelationsMr. Perry C. Siatis (Age 49)Executive VP, General Counsel & Secretary Mr. Sanjay NarayanSenior VP, Chief Ethics, Compliance Officer & Allergan Aesthetic LegalMr. Timothy J. Richmond (Age 58)Executive VP & Chief Human Resources Officer Compensation: $1.12M More Insider Trading Tools from MarketBeat Related Companies Eli Lilly and Company Insider Ownership Johnson & Johnson Insider Ownership Merck & Co., Inc. Insider Ownership Pfizer Insider Ownership Bristol-Myers Squibb Insider Ownership Zoetis Insider Ownership Royalty Pharma Insider Ownership Jazz Pharmaceuticals Insider Ownership Corcept Therapeutics Insider Ownership Perrigo Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NYSE:ABBV) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbbVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AbbVie With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
